Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is one of the best small cap stocks to buy for 10x potential. On May 4, Stifel ...

On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity ...

The stock market saw gains on May 15, with Sensex rising 451.46 points and Nifty 50 up 143.25 points, led by IT stocks. Oil ...

Novo Nordisk and Biogen are underpriced and stand to gain from new indications for their blockbuster therapies.

An outbreak of the hantavirus on a cruise ship recently sparked a bit of a rally in the pharmaceutical and biotech industries ...

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) reported first-quarter revenue of $2.71 million on May 6, compared with analyst ...

Is TEVA a good stock to buy? We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra ...

After several challenging quarters, Regeneron's sales growth is rebounding. In the first quarter, the company's revenue rose ...

Top 10 mid-cap stocks by YTD performance amid market volatility—see 600%+ gainers across semis, biotech & more, plus mid-cap ...

Top picks include a consensus buy on NMDC, alongside Zydus Lifesciences, Varun Beverages (VBL), Max Healthcare, and Tata ...

ICICI Direct maintained a 'Buy' rating with a target price of Rs 5,750. The firm highlighted that revenues grew, driven by established power brands such as Eliquis, Magnex, and Meronem.

The Indian stock market ended Friday's session on a higher note. Sumeet Bagadia of Choice Broking recommends five breakout ...